Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention.

Plenty is a vertical farming company delivering fresh, pesticide-free produce to customers. Get your hands on high-quality greens without harmful chemicals.

Birst empowers users to easily create and use analytical applications without needing specialized skills. By automating complex tasks, this platform simplifies the process for regular individuals, making business intelligence more accessible and efficient.

Insitro uses machine learning and biology to revolutionize drug discovery. Their innovative approach transforms the process, making it more efficient and effective.

Carrum Health is a platform connecting individuals with scheduled medical procedures. Access top-tier healthcare providers at competitive prices. Experience hassle-free coordination and payment for your treatment.

Veracyte is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in thyroid cancer, lung cancer, breast cancer, and idiopathic pulmonary fibrosis are available to patients, and its lymphoma subtyping test is in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide.

Sutro Biopharma is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

ArsenalBio is building a programmable cell therapy company to create highly effective and accessible immune cell therapies to impact outcomes for a much broader number of patients, initially those with cancer. Founded in 2019, ArsenalBio is focused on integrating technologies such as CRISPR-based genome engineering, scaled and high throughput target identification, synthetic biology, and machine learning to advance a new paradigm to discover and develop immune cell therapies. With its programmable and computationally driven approach, ArsenalBio aspires to evolve critical metrics of success for immune cell therapies, including enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access.

Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care. The company was founded in 2016 and is based in South San Francisco, California, United States.

Cellares revolutionizes cell therapy manufacturing, streamlining processes for optimal efficiency. Their innovative technology enhances production capabilities, leading the way in the advancement of regenerative medicine.

Bright Pattern offers cutting-edge multichannel cloud contact center software, empowering businesses to efficiently engage with customers.

Birst empowers users to easily create and use analytical applications without needing specialized skills. By automating complex tasks, this platform simplifies the process for regular individuals, making business intelligence more accessible and efficient.

Bright Pattern offers cutting-edge multichannel cloud contact center software, empowering businesses to efficiently engage with customers.

Genesis Therapeutics combines AI and biotech to speed up drug discovery, creating new medicines.

Dama Financial offers financial services for businesses in restricted industries. Simplifying banking solutions, Dama provides safe and compliant transactions for industries such as cannabis and hemp.

Coinroll is a Delaware C corporation creating coinroll.app, a fintech platform for institutional investors. The platform streamlines digital investments, offering real-time insights on new opportunities.

Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention.

Insitro uses machine learning and biology to revolutionize drug discovery. Their innovative approach transforms the process, making it more efficient and effective.

Carrum Health is a platform connecting individuals with scheduled medical procedures. Access top-tier healthcare providers at competitive prices. Experience hassle-free coordination and payment for your treatment.

Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention.

Plenty is a vertical farming company delivering fresh, pesticide-free produce to customers. Get your hands on high-quality greens without harmful chemicals.

Insitro uses machine learning and biology to revolutionize drug discovery. Their innovative approach transforms the process, making it more efficient and effective.

Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention.

Veracyte is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in thyroid cancer, lung cancer, breast cancer, and idiopathic pulmonary fibrosis are available to patients, and its lymphoma subtyping test is in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide.

Plenty is a vertical farming company delivering fresh, pesticide-free produce to customers. Get your hands on high-quality greens without harmful chemicals.

Birst empowers users to easily create and use analytical applications without needing specialized skills. By automating complex tasks, this platform simplifies the process for regular individuals, making business intelligence more accessible and efficient.

Midjourney is an AI-driven art generator that enhances creativity and expands human imagination. This self-funded team prioritizes design and AI, empowering users to explore innovative artistic mediums and unlock new realms of creative expression.

Flintk12 Inc. is a pioneering AI platform tailored for educational institutions. The platform recognizes the transformative potential of AI in education and bridges the gap between technology and classroom engagement. Flintk12 ensures data security and privacy, not using student chat data to train AI models. The platform provides features supporting multiple AI models, custom roles, and document/link uploads, aiming to redefine the modern classroom experience.

Bright Pattern offers cutting-edge multichannel cloud contact center software, empowering businesses to efficiently engage with customers.